[{"Assets_0_Q1_USD":26445500000.0,"CIK":"875045","Country":"United States","EarningsPerShareBasic_1_Q1_USD":7.17,"EarningsPerShareDiluted_1_Q1_USD":7.15,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"32775642095.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1459500000.0,"NetIncomeLossConverted_1_Q1_USD":1408800000.0,"OfficialName":"Biogen Inc. Common Stock","RevenuesConverted_1_Q1_USD":3489800000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":13822000000.0,"StockholdersEquity_0_Q1_USD":13829900000.0,"Ticker":"BIIB","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":197000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":196600000.0,"filed":"20190424","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2019.0","name":"BIOGEN INC.","period":"20190331","qtrs":"0","uom":"USD"}]